Grygorova I.A., professor of M.D., Teslenko O.O., docent, Grygorova A.A., C. of M.S., Tikhonova L.V., docent, Pogrebniak O.O., docent
Kharkov National Medical University, Ukraine
The article reviews the experience of applying Movixicam® ODT in treatment of pain syndrome in 77 patients with pain syndrome of various origins against a background of dysphagia. A positive therapeutic effect of varying degrees was observed in 98 % of cases in the form of a considerable decrease in the pain intensity, which meant a higher degree of the motor function. The convenience of oral disperse form of meloxicam expands the range of its application even in the patients with swallowing disorders.